发明申请
US20100074867A1 P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE
审中-公开
丙型肝炎病毒NS3蛋白酶的P1不可逆化的卡特非敏抑制剂
- 专利标题： P1-NONEPIMERIZABLE KETOAMIDE INHIBITORS OF HCV NS3 PROTEASE
- 专利标题（中）： 丙型肝炎病毒NS3蛋白酶的P1不可逆化的卡特非敏抑制剂
-
申请号： US12532226申请日： 2008-03-20
-
公开(公告)号： US20100074867A1公开(公告)日： 2010-03-25
- 发明人: Srikanth Venkatraman , F. George Njoroge , Francisco Velazquez , Wanli Wu , Vincent S. Madison , Neng-Yang Shih
- 申请人： Srikanth Venkatraman , F. George Njoroge , Francisco Velazquez , Wanli Wu , Vincent S. Madison , Neng-Yang Shih
- 申请人地址： US NJ Kennilworth
- 专利权人： Schering Corporation Patent Department, K-6-1; 1990
- 当前专利权人： Schering Corporation Patent Department, K-6-1; 1990
- 当前专利权人地址： US NJ Kennilworth
- 国际申请： PCT/US08/03652 WO 20080320
- 主分类号： A61K31/403
- IPC分类号： A61K31/403 ; C07D209/52 ; C07D401/12 ; A61K31/454 ; A61K38/21 ; A61K31/7056 ; A61P31/12
摘要：
The present invention discloses novel compounds, which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
公开/授权文献
信息查询
